Trial comparisons

Response

The first 2 of this page's 20 results. GET /api/comparisons/v1?page=86

{
  "data": {
    "total": 85013,
    "results": [
      {
        "id": "NCT04605159-e93aa921",
        "title": "RSV MAT Group - Infant vs Placebo Group - Infant: Number of Infant Participants With RSV-associated Hospitalizations From Birth to Day 366 Post-birth",
        "summary": "41 of 3426 against 26 of 1711; risk difference -0.3 points, 95% interval -1.1 to 0.3; NCT04605159, A Phase III, Double-blind Study to Assess Safety and Efficacy of an RSV Maternal Unadjuvanted Vaccine, in Pregnant Women and Infants Born to Vaccinated Mothers",
        "record": "/library/comparisons/NCT04605159-e93aa921",
        "nct_id": "NCT04605159",
        "kind": "outcome",
        "participants": 5137,
        "risk_difference": {
          "value": -0.0032284831195966614,
          "lower": -0.010876692740528219,
          "upper": 0.0031707646215040812
        },
        "group_1": "41 of 3,426",
        "group_2": "26 of 1,711",
        "difference": "-0.3 points",
        "interval": "-1.1 to 0.3",
        "trial_title": "A Phase III, Double-blind Study to Assess Safety and Efficacy of an RSV Maternal Unadjuvanted Vaccine, in Pregnant Women and Infants Born to Vaccinated Mothers"
      },
      {
        "id": "NCT05714644-7dd28bdc",
        "title": "Mailed FIT Kit vs Cologuard: CRC Screening Completion Rates",
        "summary": "649 of 2435 against 854 of 2692; risk difference -5.1 points, 95% interval -7.5 to -2.6; NCT05714644, Community Collaboration to Advance Racial/Ethnic Equity in CRC Screening",
        "record": "/library/comparisons/NCT05714644-7dd28bdc",
        "nct_id": "NCT05714644",
        "kind": "outcome",
        "participants": 5127,
        "risk_difference": {
          "value": -0.050706481444755314,
          "lower": -0.07546961808049306,
          "upper": -0.025792076588023623
        },
        "group_1": "649 of 2,435",
        "group_2": "854 of 2,692",
        "difference": "-5.1 points",
        "interval": "-7.5 to -2.6",
        "trial_title": "Community Collaboration to Advance Racial/Ethnic Equity in CRC Screening"
      }
    ],
    "no_events": 33758,
    "columns": [
      {
        "key": "title",
        "label": "Comparison"
      },
      {
        "key": "group_1",
        "label": "With the outcome",
        "under": "group_2"
      },
      {
        "key": "difference",
        "label": "Risk difference, 95% interval",
        "under": "interval"
      },
      {
        "key": "participants",
        "label": "Participants"
      },
      {
        "key": "nct_id",
        "label": "Trial",
        "under": "trial_title"
      }
    ],
    "order": "Most participants first",
    "kinds": {
      "all": 85013,
      "outcome": 33568,
      "serious-adverse-events": 31897,
      "deaths": 19548
    }
  },
  "release": "trial-comparisons-2026-03-23-0.1.0",
  "terms": [
    {
      "source": "ClinicalTrials.gov's posted results, through CTTI's AACT",
      "license": "ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299",
      "notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.",
      "short": "Freely available. Acknowledgement requested"
    },
    {
      "source": "ClinicalTrials.gov",
      "license": "none stated",
      "notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.",
      "short": "None stated"
    }
  ],
  "next": "/api/comparisons/v1?page=87",
  "request_id": "smpndDn8lhCNrcWt"
}